Praveen Bommareddy

Company: Replimune

Job title: Senior Director - Translational Research

Seminars:

Novel Combination Using Next Generation HSV-1 Oncolytic Immunotherapy 2:00 pm

• Development of the next generation oncolytic HSV-1 immunotherapy • RP1 combined with nivolumab overcomes resistance in PD-1 failed melanoma • RP1 monotherapy is safe and effective in solid organ transplant recipientsRead more

day: Day Two